|
| | Publication Year | Title | Author(s) |
| 301 | Dec-2020 | 2020 SNMMI Highlights Lecture: Oncology and Therapy, Part 1. | Scott, Andrew M |
| 302 | Dec-2020 | Inguinal lymph node dissection for penile cancer: a contemporary review. | Teh, Jiasian ; Duncan, Catriona; Qu, Liang G ; Guerra, Glen; Narasimhan, Vignesh; Pham, Toan; Lawrentschuk, Nathan |
| 303 | 28-Nov-2020 | Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer. | Kwan, Kim H; Burvenich, Ingrid J G; Centenera, Margaret M; Goh, Yit Wooi; Rigopoulos, Angela; Dehairs, Jonas; Swinnen, Johannes V; Raj, Ganesh V; Hoy, Andrew J; Butler, Lisa M; Scott, Andrew M ; White, Jonathan M; Ackermann, Uwe |
| 304 | 27-Nov-2020 | Response evaluation and survival prediction following PD-1 immunotherapy in patients with non-small-cell lung cancer: comparison of assessment methods. | Ayati, Narjess ; Lee, Sze Ting ; Zakavi, Seyed Rasoul; Cheng, Melissa; Lau, Eddie ; Parakh, Sagun ; Pathmaraj, Kunthi ; Scott, Andrew M |
| 305 | 26-Nov-2020 | The role of BCL-2 family proteins and therapeutic potential of BH3-mimetics in malignant pleural mesothelioma. | Arulananda, Surein; Lee, Erinna F; Fairlie, W Douglas; John, Thomas |
| 306 | 18-Nov-2020 | Cancer in Lockdown: Impact of the COVID-19 Pandemic on Patients with Cancer. | Moraliyage, Harsha; Silva, Daswin De; Ranasinghe, Weranja; Adikari, Achini; Alahakoon, Damminda; Prasad, Raj; Lawrentschuk, Nathan; Bolton, Damien M |
| 307 | 9-Nov-2020 | Automated synthesis of 18F radiolabelled indole containing Oncrasin-like molecules; a comparison of iodonium salts and boronic ester chemistry. | McDonald, Alexander F; Goh, Yit Wooi; White, Jonathan M; Scott, Andrew M ; Ackermann, Uwe |
| 308 | 1-Nov-2020 | Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients With Elevated CEA. | Gulhati, Pat; Yin, Jun; Pederson, Levi; Schmoll, Hans-Joachim; Hoff, Paulo; Douillard, Jean-Yves; Hecht, J Randolph; Tournigand, Christophe; Tebbutt, Niall C ; Chibaudel, Benoist; Gramont, Aimery De; Shi, Qian; Overman, Michael James |
| 309 | Nov-2020 | Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer. | de Boer, Richard; Hui, Rina; Lim, Elgene; Yeo, Belinda ; Zdenkowski, Nicholas |
| 310 | Nov-2020 | Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis. | Papadimitrakopoulou, V A; Mok, T S; Han, J-Y; Ahn, M-J; Delmonte, A; Ramalingam, S S; Kim, S W; Shepherd, F A; Laskin, J; He, Y; Akamatsu, H; Theelen, W S M E; Su, W-C; John, Thomas ; Sebastian, M; Mann, H; Miranda, M; Laus, G; Rukazenkov, Y; Wu, Y-L |
| 311 | Nov-2020 | "First Do No Harm": Significance of Delays from Diagnosis to Surgery in Patients with Non-metastatic Breast Cancer. | Xu, Jennifer; Bromley, Luke; Chew, Grace ; Yeo, Belinda |
| 312 | Nov-2020 | A preliminary assessment of oral monepantel's tolerability and pharmacokinetics in individuals with treatment-refractory solid tumors. | Mislang, Anna; Mollard, Richard; Tapia Rico, Gonzalo; Fairlie, Walter Douglas ; Lee, Erinna F; Harris, Tiffany J ; Aston, Roger; Brown, Michael P |
| 313 | 31-Oct-2020 | BCL-XL is an actionable target for treatment of malignant pleural mesothelioma. | Arulananda, Surein; O'Brien, Megan; Evangelista, Marco; Harris, Tiffany J ; Steinohrt, Nikita S; Jenkins, Laura J; Walkiewicz, Marzena; O'Donoghue, Robert J J; Poh, Ashleigh R; Thapa, Bibhusal ; Williams, David S ; Leong, Trishe; Mariadason, John M ; Li, Xia; Cebon, Jonathan S ; Lee, Erinna F; John, Thomas ; Fairlie, Walter Douglas |
| 314 | 28-Oct-2020 | Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway. | Yang, Yang; Huynh, Nhi; Dumesny, Chelsea; Wang, Kai; He, Hong ; Nikfarjam, Mehrdad |
| 315 | 26-Oct-2020 | Caution in Expanding the Use of Abbreviated R-CHOP to Poor-Risk Limited-Stage DLBCL. | Hawkes, Eliza A ; Opat, Stephen; Hertzberg, Mark |
| 316 | 16-Oct-2020 | Antibody-Drug Conjugates for Cancer Therapy. | Hafeez, Umbreen ; Parakh, Sagun ; Gan, Hui K ; Scott, Andrew M |
| 317 | 2-Oct-2020 | Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma. | Chia, Puey Ling ; Parakh, Sagun ; Tsao, Ming-Sound; Pham, Nhu-An; Gan, Hui K ; Cao, Diana; Burvenich, Ingrid J G; Rigopoulos, Angela; Reilly, Edward B; John, Thomas ; Scott, Andrew M |
| 318 | 1-Oct-2020 | Long-term Follow-up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients with Advanced Melanoma: KEYNOTE-029 Part 1B. | Carlino, Matteo S; Menzies, Alexander M; Atkinson, Victoria; Cebon, Jonathan S ; Jameson, Michael B; Fitzharris, Bernard M; McNeil, Catriona M; Hill, Andrew G; Ribas, Antoni; Atkins, Michael B; Thompson, John A; Hwu, Wen-Jen; Hodi, F Stephen; Guminski, Alexander D; Kefford, Richard; Wu, Haiyan; Ibrahim, Nageatte; Homet Moreno, Blanca; Long, Georgina V |
| 319 | 1-Oct-2020 | Generation of reporter cell lines for factors inducing muscle wasting in cancer cachexia. | Cao, Zhipeng; Jose, Irvin; Glab, Jason; Puthalakath, Hamsa; Osellame, Laura D; Hoogenraad, Nick J |
| 320 | Oct-2020 | Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia. | Ryland, Georgina L; Barraclough, Allison ; Fong, Chun Yew ; Fleming, Shaun; Bajel, Ashish; Hofmann, Oliver; Westerman, David; Grimmond, Sean; Blombery, Piers |
